Global Circulating Tumor Cell (CTC) Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Circulating Tumor Cell (CTC) Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CTC Enrichment
  • 1.4.3 CTC Detection
• 1.5 Market by Application
  • 1.5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and clinics
  • 1.5.3 Pharmaceuticals and biotechnology companies
  • 1.5.4 Academic research institutes
  • 1.5.5 CROs
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Perspective (2015-2026)
• 2.2 Global Circulating Tumor Cell (CTC) Diagnostics Growth Trends by Regions
  • 2.2.1 Circulating Tumor Cell (CTC) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Circulating Tumor Cell (CTC) Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Circulating Tumor Cell (CTC) Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Circulating Tumor Cell (CTC) Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Market Size
  • 3.1.1 Global Top Circulating Tumor Cell (CTC) Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio
  • 3.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2019
• 3.3 Circulating Tumor Cell (CTC) Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Circulating Tumor Cell (CTC) Diagnostics Product Solution and Service
• 3.5 Date of Enter into Circulating Tumor Cell (CTC) Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Circulating Tumor Cell (CTC) Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Circulating Tumor Cell (CTC) Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 6.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 7.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 8.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in China (2019-2020)
• 8.3 China Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 8.4 China Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 9.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

10 SoutheastAsia

• 10.1 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 10.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in SoutheastAsia (2019-2020)
• 10.3 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 10.4 SoutheastAsia Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 11.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in India (2019-2020)
• 11.3 India Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 11.4 India Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

12 Central& South America

• 12.1 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size (2015-2020)
• 12.2 Circulating Tumor Cell (CTC) Diagnostics Key Players in Central& South America (2019-2020)
• 12.3 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Type (2015-2020)
• 12.4 Central& South America Circulating Tumor Cell (CTC) Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 ApoCell, Inc.(US)
  • 13.1.1 ApoCell, Inc.(US) Company Details
  • 13.1.2 ApoCell, Inc.(US) Business Overview
  • 13.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.1.4 ApoCell, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020))
  • 13.1.5 ApoCell, Inc.(US) Recent Development
• 13.2 Biocep Ltd. (Israel)
  • 13.2.1 Biocep Ltd. (Israel) Company Details
  • 13.2.2 Biocep Ltd. (Israel) Business Overview
  • 13.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.2.4 Biocep Ltd. (Israel) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.2.5 Biocep Ltd. (Israel) Recent Development
• 13.3 Biocept, Inc.(US)
  • 13.3.1 Biocept, Inc.(US) Company Details
  • 13.3.2 Biocept, Inc.(US) Business Overview
  • 13.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.3.4 Biocept, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.3.5 Biocept, Inc.(US) Recent Development
• 13.4 Biofluidica MicrotechnologiesLLc(US)
  • 13.4.1 Biofluidica MicrotechnologiesLLc(US) Company Details
  • 13.4.2 Biofluidica MicrotechnologiesLLc(US) Business Overview
  • 13.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.4.4 Biofluidica MicrotechnologiesLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Development
• 13.5 Celltraffix Inc.(US)
  • 13.5.1 Celltraffix Inc.(US) Company Details
  • 13.5.2 Celltraffix Inc.(US) Business Overview
  • 13.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.5.4 Celltraffix Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.5.5 Celltraffix Inc.(US) Recent Development
• 13.6 ClearbridgeBiomedics(Singapore)
  • 13.6.1 ClearbridgeBiomedics(Singapore) Company Details
  • 13.6.2 ClearbridgeBiomedics(Singapore) Business Overview
  • 13.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.6.4 ClearbridgeBiomedics(Singapore) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.6.5 ClearbridgeBiomedics(Singapore) Recent Development
• 13.7 Creatv Microtech, Inc.(US)
  • 13.7.1 Creatv Microtech, Inc.(US) Company Details
  • 13.7.2 Creatv Microtech, Inc.(US) Business Overview
  • 13.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.7.4 Creatv Microtech, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.7.5 Creatv Microtech, Inc.(US) Recent Development
• 13.8 CynvenioBiosystems, Inc.(US)
  • 13.8.1 CynvenioBiosystems, Inc.(US) Company Details
  • 13.8.2 CynvenioBiosystems, Inc.(US) Business Overview
  • 13.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.8.4 CynvenioBiosystems, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.8.5 CynvenioBiosystems, Inc.(US) Recent Development
• 13.9 EpicBiosciencesInc.(US)
  • 13.9.1 EpicBiosciencesInc.(US) Company Details
  • 13.9.2 EpicBiosciencesInc.(US) Business Overview
  • 13.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.9.4 EpicBiosciencesInc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.9.5 EpicBiosciencesInc.(US) Recent Development
• 13.10 FluxionBiosciences, Inc.(US)
  • 13.10.1 FluxionBiosciences, Inc.(US) Company Details
  • 13.10.2 FluxionBiosciences, Inc.(US) Business Overview
  • 13.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 13.10.4 FluxionBiosciences, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 13.10.5 FluxionBiosciences, Inc.(US) Recent Development
• 13.11 Ikonisys, Inc.(US)
  • 10.11.1 Ikonisys, Inc.(US) Company Details
  • 10.11.2 Ikonisys, Inc.(US) Business Overview
  • 10.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.11.4 Ikonisys, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.11.5 Ikonisys, Inc.(US) Recent Development
• 13.12 IVDiagnostics, Inc.(US)
  • 10.12.1 IVDiagnostics, Inc.(US) Company Details
  • 10.12.2 IVDiagnostics, Inc.(US) Business Overview
  • 10.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.12.4 IVDiagnostics, Inc.(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.12.5 IVDiagnostics, Inc.(US) Recent Development
• 13.13 JanssenDiagnosticsLLc(US)
  • 10.13.1 JanssenDiagnosticsLLc(US) Company Details
  • 10.13.2 JanssenDiagnosticsLLc(US) Business Overview
  • 10.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.13.4 JanssenDiagnosticsLLc(US) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.13.5 JanssenDiagnosticsLLc(US) Recent Development
• 13.14 QIAGEnHannoverGmbH (Germany)
  • 10.14.1 QIAGEnHannoverGmbH (Germany) Company Details
  • 10.14.2 QIAGEnHannoverGmbH (Germany) Business Overview
  • 10.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.14.4 QIAGEnHannoverGmbH (Germany) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.14.5 QIAGEnHannoverGmbH (Germany) Recent Development
• 13.15 RARECELLsSAs(Italy)
  • 10.15.1 RARECELLsSAs(Italy) Company Details
  • 10.15.2 RARECELLsSAs(Italy) Business Overview
  • 10.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.15.4 RARECELLsSAs(Italy) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.15.5 RARECELLsSAs(Italy) Recent Development
• 13.16 ScreenCell(France)
  • 10.16.1 ScreenCell(France) Company Details
  • 10.16.2 ScreenCell(France) Business Overview
  • 10.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.16.4 ScreenCell(France) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.16.5 ScreenCell(France) Recent Development
• 13.17 STEMCELlTechnologies, Inc.(Canada)
  • 10.17.1 STEMCELlTechnologies, Inc.(Canada) Company Details
  • 10.17.2 STEMCELlTechnologies, Inc.(Canada) Business Overview
  • 10.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Introduction
  • 10.17.4 STEMCELlTechnologies, Inc.(Canada) Revenue in Circulating Tumor Cell (CTC) Diagnostics Business (2015-2020)
  • 10.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer